ABC News spotlights how MIT researchers have found that a lobster’s membrane could serve as inspiration for developing new forms of body armor. “The membrane on a lobster’s underbelly is as strong as the rubber on car tires. It could be used as a guide for body armor that allows more mobility without sacrificing protection.”
Newsweek reporter Hannah Osborne writes that MIT researchers have found that a lobster’s membrane, which protects its underbelly, is made of one of the toughest hydrogels in the world. “Its strength and flexibility,” Osborne explains, could “make it an ideal material to use as a blueprint for body armor.”
Washington Post reporter Peter Holley writes that MIT researchers have found that the soft membrane covering a lobster’s joints and abdomen is as tough as industrial rubber. The researchers discovered, “lobsters could offer a solution to the problem plaguing most modern body armors: the more mobility an armor offers, the less it protects the wearer’s body.”
Forbes reporter Chuck Tannert spotlights alumnus R.J. Scaringe, founder and CEO of the electric vehicle company Rivian Automotive. Scaringe explains his motivation to build electric vehicles: “It was frustrating knowing the things I loved were simultaneously the things that were making the air dirtier and causing all sorts of issues, everything from geopolitical conflict to the smog to climate change.”
MIT researchers have developed a new ingestible capsule that in the future could be used to deliver medication to diabetes patients, reports Dr. Erica Orsini for ABC News. “The oral route is preferred by both patients and health care providers,” explains visiting scientist Giovanni Traverso.
A new ingestible pill developed by MIT researchers positions itself against the walls of the stomach and can deliver insulin directly to the bloodstream, reports Gina Kolata for The New York Times. “It’s a very new concept and a really cool idea,” says Edith Mathiowitz, a professor of medical science and engineering at Brown University.
Financial Times reporter Clive Cookson writes that MIT researchers have developed an ingestible pill that can deliver insulin directly to a patient’s stomach. “This discovery has the potential to transform not only drug delivery but drug discovery as well,” explains Prof. Robert Langer, “since most current drug discovery efforts are aimed at creating small molecule drugs that patients can take orally.”
MIT researchers have developed a new ingestible capsule that can release insulin directly into the stomach and could be used to treat type 2 diabetes, reports Joe Palca for NPR. "We chose the stomach as the site of delivery because we recognized that the stomach is a thick and robust part of the GI tract," explains visiting scientist Giovanni Traverso.
Wired reporter Megan Molteni writes that MIT researchers have developed an ingestible capsule that could be used to deliver insulin to diabetes patients. The researchers were inspired by the leopard tortoise to create a self-orienting device that can position itself to deliver medication directly into the stomach. “The result was a roly-poly-pill that autonomously rights itself to be needle-down,” Molteni explains.
Associated Press reporter Lauran Neergaard writes that MIT researchers have created a pea-sized pill that, once swallowed, can deliver medications such as insulin directly to the stomach. “The way this works is it travels down the esophagus in seconds, it’s in the stomach within a few minutes, and then you get the drug,” explains visiting scientist Giovanni Traverso.
Inspired by the shell of a leopard tortoise, MIT researchers have developed a self-orienting ingestible capsule that can deliver doses of medication to the stomach, writes Megan Thielking for STAT. “If we’re able to deliver large molecules orally, it would not only change drug delivery but also drug discovery,” says Prof. Robert Langer.
A team of MIT researchers has created a tiny ingestible device that deliver medications such as insulin directly to the stomach and could replace the daily injections used to treat diabetes patients, reports Alice Park for TIME. “We see no reason why someday this couldn’t be used to deliver any protein to the body,” says Prof. Robert Langer.
Boston Globe reporter Martin Finucane writes that MIT researchers have developed an ingestible capsule that contains a small needle that injects insulin directly into the stomach. Finucane writes that the researchers “designed the pill with a special shape to ensure that it will fall and then orient itself at the bottom of the stomach so that the needle is facing toward the stomach lining rather than the stomach’s inside.”
In this video, graduate student Nima Fazeli speaks with the BBC News about his work developing a robot that uses sensors and cameras to learn how to play Jenga. “It’s using these techniques from AI and machine learning to be able to predict the future of its actions and decide what is the next best move,” explains Fazeli.
CBS This Morning spotlights how MIT researchers have developed a new robot that can successfully play Jenga. “It is an automated system that has had a learning period first,” explains Prof. Alberto Rodriguez. “It uses the information from the camera and the force sensor to interpret its interactions with the Jenga tower.”